Dr. Kathy Fosnaugh has 25 years of experience in biotech research and development. Most recently she was Director of Research at Youtell Biochemical. Prior to this, as Associate Director of Discovery Research and Pharmaceutical Development at Marina Therapeutics (formerly Nastech Pharmaceuticals), Dr. Fosnaugh was instrumental in nucleic acid therapeutics and delivery programs in cancer, autoimmune, and metabolic disease areas. Previously she held scientist positions at Sirna Therapeutics and Ligand Pharmaceuticals. She has published 13 scientific articles and co-authored 17 patents. Kathy received her BS and PhD degrees in microbiology from the University of Illinois and Cornell University, respectively, followed by postdoctoral research in developmental biology at the University of California, San Diego.